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Daxx, a Novel Fas-Binding Protein
That Activates JNK and Apoptosis
Xiaolu Yang,* Roya Khosravi-Far,* a C-terminal death domain that interacts with Fas and
an N-terminal domain that can induce cell death (BoldinHoward Y. Chang,* and David Baltimore
Department of Biology et al., 1995b; Chinnaiyan et al., 1995). The N terminus
of FADD interacts with MACH/FLICE, an interleukin-1b-Massachusetts Institute of Technology
Cambridge, Massachusetts 02139 converting enzyme (ICE) family cysteine protease (cas-
pase) that potently induces apoptosis (Boldin et al.,
1996; Muzio et al., 1996). Although the details are notSummary
yet clear, other caspases, including ICE and CPP32, are
sequentially activated to execute the apoptotic dissolu-The Fas cell surface receptor induces apoptosis upon
tion of the cell (Enari et al., 1996). TNFR1 also interactsreceptor oligomerization. We have identified a novel
with FADD via an adaptor protein termed TRADD (Hsusignaling protein, termed Daxx, that binds specifically
et al., 1996). The emerging model from these molecularto the Fas death domain. Overexpression of Daxx en-
studies is that Fas, via FADD, directly engages and acti-hances Fas-mediated apoptosis and activates the Jun
vates apoptotic ICE family proteases. However, thisN-terminal kinase (JNK) pathway. A C-terminal portion
model fails to explain how Bcl-2 and other physiologicof Daxx interacts with the Fas death domain, while a
signals may modulate Fas-mediated apoptosis (Fraserdifferent region activates both JNK and apoptosis. The
and Evan, 1996). It remains possible that other signalingFas-binding domain of Daxx is a dominant-negative
molecules in addition to FADD are involved in Fas-medi-inhibitor of both Fas-induced apoptosis and JNK acti-
ated apoptosis.vation, while the FADD death domain partially inhibits
Fas can also activate the Jun N-terminal kinase/deathbut not JNK activation. The Daxx apoptotic path-
stress-activated protein kinase (JNK/SAPK) pathwayway is sensitive to both Bcl-2 and dominant-negative
(Latinis and Koretzky, 1996; Goillot et al., 1997; Lenc-JNK pathway components and acts cooperatively with
zowski et al., 1997). Analogous to the MAP kinase cas-the FADD pathway. Thus, Daxx and FADD define two
cade, the prototypical JNK/SAPK pathway involves thedistinct apoptotic pathways downstream of Fas.
sequential activation of theproteins MEKK1, SEK1, JNK,
and c-Jun. Other targets of the JNK pathway include
the transcription factors Elk-1 and ATF-2 (reviewed byIntroduction
Kyriakis and Avruch, 1996). This pathway was initially
characterized by the ability of UV irradiation and trans-Fas (also known as CD95 or APO-1) is a widely ex-
pressed cell death receptor that has a critical role in the forming Ha-Ras to activate the AP-1 transcription factor;
regulation of the immune system and tissue homeosta- subsequently, it was shown that TNF-a and other stress-
sis. Fas is activated by Fas ligand (FasL), a trimeric activated signals may also activate this pathway. The
transmembrane protein (reviewed by Nagata, 1997). Fas significance of Fas-mediated JNK activation has been
is thought to have an essential role in deleting autoreac- unclear. One hypothesis is that activation of the JNK
tive lymphocytes and maintaining peripheral tolerance. pathway contributes to Fas-mediated apoptosis (Goillot
Inherited Fas mutations in humans and mice cause a et al., 1997). Dominant-negative constituents of the JNK
syndrome of massive lymphoproliferation and autoanti- pathway can block stress- and TNF-induced apoptosis
body production (reviewed by Nagata, 1997).Fas-induced in several cell lines, suggesting that activation of the
apoptosis is also a major mechanism in cytotoxic T JNK pathway is required for these apoptotic inducers
lymphocyte±mediated cytolysis and in the maintenance (Verheij et al., 1996). Similarly, in PC12 cells that undergo
of immune privilege sites (reviewed by Abbas, 1996). apoptosis in response to nerve growth factor with-
Moreover, depending on the signal from the B cell anti- drawal, activation of the JNK pathway in concert with
gen receptor, Fas may induce either apoptosis or prolif- the suppression of the ERK pathway is critical to induc-
eration of B cells in vivo (Rathmell et al., 1996). tion of programmed cell death (Xia et al., 1995). Alterna-
Fas belongs to the tumor necrosis factor (TNF) recep- tively, Fas-mediated JNK activation may drive cellular
tor superfamily, which includes TNF receptor 1 (TNFR1), proliferation via activation of the proto-oncogene c-Jun
TNFR2, CD40, and the p75 low affinity NGF receptor; and AP-1 transcriptional activity (Rathmell et al., 1996).
these receptors share characteristic cysteine-rich re- Recently, Liu et al. have demonstrated that overex-
peats in their extracellular domains (reviewed by Smith pression of FADD, the established downstream signal
et al., 1994). The intracellular tails of Fas and TNFR1 transducer of Fas, cannot activate JNK but that two
share homologous death domains, an approximately 80 other proteins engaged by TNFR1ÐRIP and TRAF2Ð
amino acid protein motif that is critical for signaling are responsible for JNK activation by TNF (Liu et al.,
apoptosis (Itoh and Nagata, 1993; Tartaglia et al., 1993). 1996). This raises the question of whether Fas also en-
Over the last two years, elucidation of the mechanism gages other proteins to activate the JNK pathway.
for Fas-mediated apoptosis has begun (reviewed by In this report, we describe the molecular cloning and
Cleveland and Ihle, 1995; Fraser and Evan, 1996). FADD, characterization of Daxx, a novel Fas-binding protein.
also known as MORT1, is a cytoplasmic protein that has Daxx binds to the Fas death domain, yet lacks a death
domain of its own. Overexpression of Daxx leads to JNK
activation and potentiates Fas-induced apoptosis. The*These authors made key independent contributions.
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Fas-binding domain of Daxx acts as a dominant-nega- To determine the tissue distribution of Daxx, we per-
formed a Northern analysis with a Daxx C-terminaltive inhibitor of Fas-induced apoptosis and JNK activa-
tion. Furthermore, using dominant-negative and consti- probe. A 2.6 kb transcript, consistent with the length of
the open reading frame, was detected in various adulttutively active forms of Daxx and FADD, we show that
Fas engages two independent pathways to induce cell mouse tissues (Figure 2B). The expression of Daxx ap-
peared uniform, with the exception of stronger expres-death: one pathway via Daxx that involves JNK activa-
tion and is blocked by Bcl-2, and a second pathway via sion in testis. Shorter hybridizing transcripts were also
detected in liver, kidney, and testis. Cell lines from manyFADD that is Bcl-2 insensitive.
tissues have been reported to support the ability of ec-
topically expressed Fas to induce apoptosis, suggesting
Results that the downstream signaling mechanism is present in
most tissues. Similarly, FADD is expressed ubiquitously
Two-Hybrid Screen for Novel in adult tissues (Boldin et al., 1995b; Chinnaiyan et al.,
Fas-Interacting Proteins 1995).
To identify novel Fas-interacting proteins, we performed
a two-hybrid screen with the death domain of murine Daxx Interacts with Fas Both In Vitro and In Vivo
Fas fused to the DNA-binding protein LexA (LexA- In the two-hybrid system, the Daxx C-terminal region
mFasDD). A plasmid library of fusions between a tran- interacted strongly with Fas, confirming that Daxx is the
scription activation domain and cDNAs from human functional homolog of clone A21 (Figure 1B). We then
HeLa cells was screened for interaction with LexA- tested the binding of full-length murine Daxx protein
mFasDD in a yeast reporter strain. One group of positive in vitro and in mammalian cells. In vitro translated,
interactors, typified by clone A21, interacted strongly 35S-labeled Daxx bound to immobilized glutathione
with FasDD. However, it interacted poorly with either S±transferase (GST) fusion proteins of Fas death domain
Fas-lprcg, an I224A mutation in the Fas death domain
that abrogates Fas signaling and causes lymphoprolifer-
ation in mice (reviewed by Nagata, 1997), or with Fas-
FD8, a functionally inactive deletion mutation of the Fas
death domain (Itoh and Nagata, 1993) (Figure 1B). Se-
quence analysis of clone A21 revealed it to encode a
portion of a novel protein.
In the two-hybrid system, clone A21 also interacted
with the intracellular domain of human Fas and the death
domain of TNFR1, but not with the intracellular region
of CD40, a closely related receptor that lacks a death
domain (Figure 1B). The sequence C-terminal to the Fas
death domain has been shown to inhibit the cytotoxicity
of Fas death domain (Itoh and Nagata, 1993), and it also
inhibits the binding of FADD to Fas (Chinnaiyan et al.,
1995). The presence of this inhibitory region had no
effect on the binding of clone A21 to Fas because clone
A21 interacted equally well with FasDD and FasIC (Fig-
ure 1B).
We mapped the Fas interaction domain on clone A21
to its C-terminal 112 amino acids by deletion analysis
(Figure 1C). This region showed no evident sequence
similarity to death domains, suggesting that the interac-
tion between clone A21 and Fas is not through a homo-
typic death domain association.
Cloning of Daxx cDNA and Northern Analysis
Figure 1. Interaction of Clone A and Daxx with Fas Death DomainUsing clone A21 as the probe, we cloned a cross-
in Yeast
hybridizing full-length murine cDNA. Sequence analysis
(A) Schematic representation of the cytoplasmic domain of murinerevealed an open reading frame able to encode a protein
Fas (Watanabe-Fukunaga et al., 1992). Boundaries of the transmem-
of 739 amino acids with a predicted molecular mass of brane domain (TM), death domain (DD), and the negative regulatory
81.4 kDa (Figure 2A). The C terminus of this protein is domain (NR) are labeled.
(B) Protein interactions in the two-hybrid system. LexA constructshomologous to clone A. We call this protein Daxx for Fas
contained the indicated sequences (amino acids in parentheses) ofdeath domain±associated protein. A database search
receptors that expressed similar level of fusion proteins in yeast.using BLAST revealed that Daxx is a novel protein with
Colony color and b-galactosidase units were determined as de-no significant sequence similarity to any other protein.
scribed in Experimental Procedures. The activation hybrid Act-
Daxx contains a region of 62 amino acids with a high DaxxC501 contained amino acids 501±739 of Daxx.
content (71%) of glutamic acid and aspartic acid and (C) The C terminus of clone A interacts with Fas death domain.
Amino acids contained in each activation hybrid are indicated.contains two small proline-rich regions (Figure 2A).
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and TNFR1 intracellular tail but not to immobilized GST,
GST-CD40 intracellular tail, or GST-Fas lprcg death do-
main (Figure3A). Daxx migrated with an apparent molec-
ular weight of approximately 120 kDa on SDS±PAGE;
this slower than expected migration may reflect the high
content of acidic residues in Daxx. In the GST pull-down
assay, 35S-Daxx bound to GST-FasDD but only very
weakly to GST-TNFR1. This discrepancy with the two-
hybrid result (Figure 1) may be due to the nonlinear
readout of the two-hybrid system. Deletion of 162 amino
acids from the C terminus of Daxx abrogated binding
to GST-FasDD, while the C-terminal 112 amino acids
(DaxxC) were sufficient to bind GST-FasDD (Figure 3B),
consistent with the two-hybrid results.
To determine whether Daxx interacted with Fas in
mammalian cells, human embryonic kidney 293 cells
were cotransfected with constructs expressing hemag-
Figure 3. Interaction of Daxx with Fas In Vitro and in Mammalianglutinin-tagged Daxx (HA-Daxx) and GST-Fas intracellu-
Cellslar tail (GST-FasIC). HA-Daxx was coprecipitated with
(A) Binding of in vitro translated 35S-Daxx to GST-fusion proteins.GST-FasIC but not with GST using glutathione beads.
Positions of MW standards (in kDa) are shown at left. Coomassie-
Again, this interaction was dependent on the C-terminus stained GST fusion proteins from the same gel were aligned to show
of Daxx (Figure 3C). GST-FasIC was also able to copre- protein levels.
cipitate HA-tagged Fas death domain, confirming that (B) Binding of full-length and truncated 35S-Daxx to GST (lanes 3,
5, and 7) and GST-FasDD (lanes 2, 4, and 6). Daxx(2162) lackeddeath domains may multimerize (data not shown). Be-
the C-terminal 162 aa of Daxx; DaxxC corresponded to aa 628±739.cause Fas is overexpressed and thereby activated, we
Input of 35S-Daxx and 35S-Daxx(2162) proteins in binding assays are
shown in lanes 1 and 2, respectively. GST fusion proteins are shown
on the bottom panel.
(C) Association of HA-Daxx and HA-DaxxDC (lacking aa 626±739)
with the GST fusion of Fas intracellular tail (GST-FasIC) in 293 cells
(top panel). The presence of HA-Daxx and HA-DaxxDC in extracts
was verified by immunoblotting for HA (bottom panel).
are uncertain whether Daxx binds to the inactive Fas.
Collectively, these data show that the C terminus of
Daxx mediates an interaction between the Fas death
domain and Daxx, and that this interaction is likely to
occur directly and in vivo.
Daxx Potentiates Fas-Mediated Apoptosis
To study the role of Daxx in Fas signaling, we chose
293 cells and HeLa cells. Both are sensitive to Fas-
and TNF-mediated apoptosis, and their normally flat
morphology facilitates the scoring of apoptotic cells,
characterized by membrane blebbing, pyknosis, and cell
body condensation (Figure 4A). Cells scored to be apo-
ptotic by morphology also exhibited nuclear condensa-
tion and fragmentation as judged by Hoechst staining
(data not shown). HeLa and 293 cells were transfected
with various expression constructs and an expression
construct for b-galactosidase; at defined times after the
transfection, cells were stained for b-galactosidase
activity to mark the transfected cells and scored for
apoptotic morphology. In 293 cells, transient overex-
pression of Fas induced apoptosis in a dose-dependentFigure 2. Daxx Sequence and mRNA Distribution
and saturable manner (Figure 4B). Fas activation in the(A) Conceptually translated amino acid sequence of Daxx protein.
The open reading frame of murine Daxx follows an in-frame stop absence of activating ligand is due to a documented
codon and begins with a Kozak consensus sequence. The regions propensity of death domains to multimerize (Boldin et
enriched for acidic residues and proline are underlined. The partial al., 1995a). However, the addition of activating anti-Fas
human cDNA sequence from A21 is shown below the mouse se- antibodies, Jo2, did not increase cell death in Fas-
quence with identical amino acids indicated by dashes.
transfected 293 cells, implying that a function down-(B) Tissue distribution of Daxx. A mouse multiple tissue Northern
stream of receptor activation may be limiting (data notblot was probed with a C-terminal 0.7 kb fragment of Daxx and a
human b-actin cDNA. shown). Overexpression of Daxx by itself did not induce
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may be a rate-limiting step downstream of receptor en-
gagement.
In an analogous approach to assess the function of
Daxx, we established murine fibroblast L929 cell lines
that stably overexpressed Daxx (L/Daxx). L/Daxx cells
are substantially more susceptible to Fas killing com-
pared to vector-transfected cells (L/EBB). This stimula-
tion effect appeared to be a kinetic one: compared to
L/EBB, the L/Daxx culture had greater than 3-fold more
apoptotic cells 24 hours after Fas transfection, but
L/EBB cells caught up by 48 hours after transfection
(Figure 4D). TNF-a-, TNFR1-, or FADD-mediated
apoptosis was not increased in L/Daxx cells (Figure 4D
and data not shown). Therefore, L/Daxx cells are not
generally more sensitive to apoptosis, but are specifi-
cally sensitized to the Fas signal, suggesting that Daxx
is a mediator of Fas-induced killing.
Daxx Activates the JNK/SAPK Pathway
The lack of death domain homology or constitutive cell
death activity suggests that Daxx may play a different
role from previously identified death domain±binding
proteins in Fas signaling. Fas has been reported to acti-
vate the JNK pathway (Latinis and Koretzky, 1996; Goil-
lot etal., 1997; Lenczowski et al., 1997), which is required
in certain cell lines for the analogous TNF-a-induced
apoptosis (Verheij et al., 1996). We therefore analyzed
the ability of Fas and Daxx to activate the kinase activity
of JNK and JNK-dependent transcription. In transient
transfection assays in 293 cells, Fas activated JNK-1,Figure 4. Daxx Potentiates Fas-Induced Apoptosis
the major JNK activity in cells (Derijard et al., 1994). Fas-(A) Normal and apoptotic 293 and HeLa cells. Cells were transiently
transfected with the indicated plasmids, stained with X-Gal, and induced JNK activation was not blocked by the serpin
examined by light microscopy. Fields were chosen to illustrate mor- ICE inhibitor crmA (Figure 5A), a peptide ICE inhibitor
phologic differences but not relative percentages of apoptosis. Z-VAD, or a peptide CPP32 inhibitor Z-DEVD (data not
Scale bar 5 50 mm.
shown; Goillot et al., 1997). FADD overexpression did(B) Daxx potentiates Fas-induced apoptosis in 293 cells. Indicated
not induce JNK activation (Figure 5A). Therefore, Fasamounts (in mg) of pEBB-Fas and pEBB-HA-Daxx plasmids were
activation of JNK is not secondary to FADD activity orcotransfected with 0.5 mg of pCMV-lacZ. Amounts of transfected
DNA were equalized by adding vector DNA. The cells were stained apoptosis. Interestingly, Daxx overexpression activated
with X-Gal 20 hr after transfection and analyzed for apoptotic mor- JNK-1 to a level similar to that of Fas (Figure 5A). To
phology as described in Experimental Procedures. assay endogenous JNK activation by Fas and Daxx, we
(C) Daxx potentiates Fas-induced apoptosis in HeLa cells. Transfec-
used L929 cells stably expressing murine Fas (L/Fas)tion and specific apoptosis were done and measured as in 293 cells
and the L/Daxx and L/EBB cells. In L/Fas cells, Fas-except that X-Gal staining was done 24 hr after transfection.
induced JNK activation was observed approximately 15(D) L929 cells stably overexpressing Daxx have accelerated
apoptosis in response to Fas. L/EBB and L/Daxx were transfected minutes after Fas ligation and reached maximal activity
with 1 mg of pEBB-Fas, pEBB-TNFR1, or pRK-FADD plus 0.2 mg of in about one hour (Figure 5A and data not shown).
pCMV-lacZ. Specific apoptosis was determined as in Figure 4B at L/Daxx cells had constitutive activation of JNK activity
indicated time after transfection. Similar results were obtained with
compared to L/EBB cells (Figure 5B), and the level ofmultiple L/Daxx lines.
JNK activation correlated with the level of Daxx overex-
pression in various L/Daxx cell lines (data not shown).
As an independent measure of JNK activity, we tested
apoptosis, but Daxx coexpression significantly en- the ability of Fas and Daxx to stimulate signaling to SRF
hanced Fas-mediated apoptosis (Figure 4B). Parallel ex- (Serum Response Factor). JNK can phosphorylate and
periments with TNFR1 did not show any enhancement activate SRF independent of the MEK/MAPK pathway,
of apoptosis by Daxx, consistent with the much lower and the level of JNK activation in vivo can be assayed
affinity of Daxx for TNFR1 (Figure 3A). using a reporter gene driven by SRE-L, a derivative of
In HeLa cells, transient transfection of Fas led to ro- SRE that specifically binds SRF (Hill et al., 1995). In 293
bust, dose-dependent, and saturable cell death (Figures cells, Fas induced SRF-dependent transcription about
4A and 4C), which was further enhanced by the addition 4-fold, and Daxx induced it about 6-fold. TNF-a,a known
of Jo2. As in 293 cells, overexpression of Daxx alone inducer of the JNK pathway, stimulated the SRF-
did not induce apoptosis in HeLa cells. In the range reporter gene to a level similar to that induced by Fas
where apoptosis was proportional to input Fas DNA, or Daxx (Figure 5C).
coexpression of Daxx significantly increased Fas-medi- Collectively, these data show that Daxx is an activator
of the JNK pathway.ated apoptosis (Figure 4C), suggesting that Daxxactivity
Daxx: A Novel Fas Effector
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Figure 5. Daxx Activates the JNK Pathway
(A) Daxx activates JNK in transient transfection. Flag-tagged JNK1
(Flag-JNK) and the indicated plasmids (1 mg each) were cotrans-
fected into 293 cells. Top: phosphorylation of GST-cJun. Bottom:
Figure 6. Deletion Analysis of Daxxexpression of Flag-JNK. The data shown are representative of four
(A) Apoptosis and JNK activation by Daxx deletion mutants. Theindependent assays.
horizontal bars represent Daxx sequences present in deletion mu-(B) Stable expression of Daxx constitutively activates JNK. Top:
tants. Apoptosis assay: 3 mg of each Daxx mutant construct wasphosphorylation of GST-cJun. Bottom: expression of endogenous
transfected into 293 cells as in Figure 4B. JNK assay: transientJNK. The data shown are representative of three independent
transfection of 1 mg of each Daxx mutant construct or pEBB vectorassays.
(v) with 1 mg of Flag-JNK and invitro JNK assaywas doneas in Figure(C) Daxx activates a JNK-dependent reporter gene. The data shown
5A. Equal Flag-JNK expression was verified by immunoblotting forare the average and SD of three independent experiments in du-
Flag.plicate.
(B) DaxxC inhibits Fas-induced apoptosis. HeLa cells were trans-
fected with 0.5 mg pEBB-Fas and pCMV-lacZ and the indicated
amount (in mg) of HA-Daxx and HA-DaxxC. Total amount of trans-
Deletion Mutagenesis of Daxx fected DNA was made constant by adding pEBB. Jo2 antibody (12.5
To further dissect Daxx signaling, we asked which re- ng/ml) was added 16 hr later. X-Gal staining was done 24 hr after
transfection.gions of Daxx were required for its three activities: Fas
(C) DaxxC inhibits Fas-induced JNK activation. Transient transfec-binding, enhancement of apoptosis, and activation of
tion of 1 mg of each indicated plasmid with 1 mg of Flag-JNK andJNK. We have already determined that the C-terminal
in vitro JNK assay were done as in Figure 5A.112 amino acids of Daxx (DaxxC) are necessary and
sufficient for Fas binding (Figure 3B). Significantly, Daxx
mutants missing either the C terminus (DaxxDC) or suggesting that full-length Daxx may activate other
pathways that counterbalance the apoptotic JNK signal.N-terminal 500 amino acids (DaxxC501) acquired a mod-
est constitutive cell death activity for 293 cells in the
absence of Fas (Figure 6A). HeLa cells and L929 cells DaxxC Is a Dominant-Negative Inhibitor of
Fas-Mediated Apoptosis and JNK Activationwere not sensitive to this activity. The result in 293 cells
suggested that deletion of either end of Daxx activated Deletion mutagenesis showed that DaxxC, the C-termi-
nal 112 amino acids of Daxx, was necessary and suffi-a normally latent cell death activity. Because DaxxDC
is unable to bind Fas death domain (Figures 3B and 3C), cient to bind Fas but more N-terminal domains were
required to activate JNK and cell death. Thus, we testedthis cell death activity is likely to be independent of
Fas or other death domain proteins. Further deletions whether DaxxC can act as a dominant-negative inhibitor
of endogenous Daxx by competing with its binding torevealed that a peptide containing amino acids 501±625,
which lies immediately N-terminal to the Fas-binding Fas. We chose to use HeLa cells in these experiments
because the cells have a robust response to transfecteddomain, contained most of the cell death activity (Fig-
ure 6A). Fas (Figure 4C) and are the source of clone A21 from
the two-hybrid screen. In Figure 6B, we show that ex-When these Daxx mutants were tested for their ability
to activate JNK, we observed that each deletion mutant pression of DaxxC gave a dose-dependent suppression
of Fas-mediated apoptosis. Fas-induced c-Jun phos-maintained some level of JNK activity with the exception
of DaxxC; the majority of the activity came from just the phorylation was also inhibited by DaxxC in HeLa cells
(data not shown) and in 293 cells (Figure 6C). To addressregion with amino acids 501±625 (Figure 6A). This result
suggests that JNK activation may be involved in Daxx- the specificity of DaxxC, we then coexpressed full-
length Daxx with DaxxC and asked if this combinationstimulated apoptosis. However, full-length Daxx acti-
vates JNK but does not cause constitutive apoptosis, now reversed the dominant-negative effect. If DaxxC
Cell
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(Figure 6) and suggest that Daxx and FADD bind inde-
pendently to Fas and activatedistinct pathways. Consis-
tent with this interpretation, FADD-induced cell death
is not blocked by DaxxC (Figure 7C). In addition, DaxxC
plus FADD(80±205) inhibited Fas-induced cell death
substantially more than saturating amounts of either
dominant-negative protein alone (Figure 7A, lanes 7).
Thus, Daxx and FADD activate apoptosis downstream
of Fas by distinct but cooperative pathways.
Fas-mediated apoptosis can be inhibited by crmA
and, in some cell types, by Bcl-2, a negative regulator
of cell death (Itoh et al., 1993; Enari et al., 1995; Los et al.,
1995; Tewari and Dixit, 1995; Lacronique et. al.,1996). To
dissect the apoptotic pathways initiated by overexpres-
sion of Fas, Daxx, and FADD, we tested the ability of
crmA, Bcl-2, SEK(AL), and TAM67 to block each apop-
totic inducer. SEK(AL) and TAM67 are dominant-nega-
tive inhibitors of the JNK pathway. SEK1 is the kinase
that phosphorylates and activates JNK; SEK(AL) en-
codes a mutant that has a single mutation at the ATP-
binding site, abrogating the kinase activity (Sanchez et
al., 1994). TAM67 is a variant of c-Jun in which amino
acids 3±122 have been deleted. This mutant can dimer-
ize and bind DNA but lacks a transcriptional activation
Figure 7. Daxx and FADD Activate Distinct Apoptotic Pathways domain (Brown et al., 1994). First, we tested the ability
(A) Inhibition of Fas-induced apoptosis by DaxxC and FADD(80± of the panel of inhibitor genes to block Fas in several
205). HeLa cells were transfected with pEBB-Fas (0.5 mg), pCMV- cell types commonly used in apoptosis studies. We
lacZ (0.5 mg), and plasmids expressing the indicated genes (in mg). found that Fas-induced apoptosis in L929, 293, and
Jo2 (12.5 ng/ml) was added 16 hr later; X-Gal staining was done 24
HeLa cellscan beblocked by crmA and Bcl-2-type inhib-hr after transfection.
itors, but only 293 cells and L929 cells required the JNK(B) FADD(80±205) fails to inhibit Fas-induced JNK activation. JNK
pathway for Fas-induced apoptosis (Figure 8A). Thiskinase activity was assayed after transient transfection of the indi-
cated plasmids (2 mg each) with Flag-JNK (2 mg). result is consistent with the work of Liu et al., who re-
(C) DaxxC does not inhibit FADD-mediated apoptosis. HeLa cells ported that the JNK pathway appeared dispensable for
were transfected with the indicated amount (in mg) of FADD and TNF-a-induced apoptosis in HeLa cells (Liu et al., 1996).
DaxxC and assayed as Figure 4C.
Kolesnick and colleagues have reported that TNF-a-
induced apoptosis is inhibited in U937 human mono-
blastic leukemiacells that stably express TAM67 (Verheij
were binding other death domain±containing proteins et al., 1996); these cells are also resistant to Fas-medi-
(e.g., FADD), coexpression of full-length Daxx would ated apoptosis (data not shown). Taken together, these
further titrateFADD away fromFas and inhibit apoptosis. observations indicate that the requirement for the JNK
Instead, coexpression of Daxx with Fas and DaxxC gave pathway in Fas-mediated apoptosis is cell-type specific.
a dose-dependent rescue of Fas-induced apoptosis We note that this type of dominant-negative experiment
(Figure 6B). This result argues that the only functions gives a positive result only if the protein in question is
made deficient by DaxxC are those of intact Daxx, im- uniquely required for a particular process. In a case
plying that DaxxC specifically competes with endoge- where a negative result (no inhibition) is obtained, it
nous Daxx but not other proteins for binding to Fas. may be that the protein in question is involved but is
These results suggest that endogenous Daxx is required functionally redundant or in great excess. The continued
for Fas-induced apoptosis and JNK activation. discovery of JNK relatives makes such scenarios plausi-
ble (Gupta et al., 1996).
Daxx and FADD Define Two Distinct Next, we tested the same panel of inhibitor genes on
Fas-Mediated Signaling Pathways FADD- and Daxx-induced apoptosis. Since full-length
Because Daxx and FADD are both required for Fas- Daxx does not induce apoptosis by itself, we used
induced apoptosis, we assessed how these two effec- two alternative strategies: we examined the apoptotic
tors may be related to each other by a dominant-nega- response of Fas plus Daxx in 293 cells (where a large
tive approach. The FADD death domain, FADD(80±205), fraction of the apoptotic response is Daxx dependent,
has been shown to block Fas-induced death presum- Figure 4B) and the apoptotic response of Daxx 501±625,
ably by preventing the binding of endogenous FADD the smallest domain that has constitutive cell death
(Chinnaiyan et al., 1996). We found that FADD(80±205) activity in 293 cells (Figure 6A). Daxx-dependent
partially inhibited Fas-induced death (Figure 7A, lanes apoptosis was blocked by crmA and Bcl-2 and required
1±3) but did not inhibit JNK activation (Figure 7B). More- the JNK pathway, which paralleled the inhibition profile
over, the effect of FADD(80±205) on cell death was not of Fas in 293 cells (Figure 8B). In contrast, FADD, which
reversed by coexpression of excess Daxx (Figure 7A, can not activate JNK, was inhibited only by crmA, but
not by Bcl-2, SEK(AL), or TAM67. Similarly, Hsu et al.lane 4). These results contrast with the effects of DaxxC
Daxx: A Novel Fas Effector
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activate the JNK pathway (Figure 5; Latinis and Koret-
zky, 1996; Goillot et al., 1997; Lenczowski et al., 1997).
JNK activation is unlikely to be secondary to apoptosis
because it is not inhibited by blocking the apoptotic
caspases (Figure 5A). The fact that FADD induces cell
death but not JNK activation provides powerful evi-
dence that Fas must engage additional signaling mole-
cules toactivate JNK. While RIP and TRAF2 are recruited
by TNFR1 to activate JNK, currently no known Fas ef-
fector can account for its JNK activation. In this study,
Daxx emerges as the missing link between Fas and the
JNK pathway. Daxx directly binds to the death domain of
Fas, and overexpressionof Daxx or its effector domain is
sufficient to activate the JNK pathway. In addition, a
specific dominant-negative inhibitor of Daxx blocksFas-
induced JNK activation. The JNK pathway is activated
by many stress stimuli (such as oxidative damage, ir-
radiation, and ischemia-reperfusion) that culminate in
apoptosis (Verheij et al., 1996), but the signaling events
upstream of the kinase cascades are poorly understood.
Daxx may have general importance in coupling other
death signals to JNK, and its effector domain should be
a useful probe for uncovering themolecular connections
that lead to JNK activation.
It is becoming increasingly clear that activation of the
Figure 8. Inhibition Profile of Daxx- and FADD-Induced Apoptosis JNK pathway can induce apoptosis. For example, ASK1,
(A) Inhibition profile of Fas-induced apoptosis in L929, 293, and an activating kinase of the JNK pathway that functions in
HeLa cells. Transfection and apoptosis analysis in L/Fas cells were response to TNF-a is both sufficient to induce apoptosis
performed as described in Experimental Procedures. As in Figure
and is required for TNF-induced cell death (Ichijo et4B, 293 cells were cotransfected with pEBB-Fas (2 mg) plus vector
al., 1997). Similarly, MEKK, the upstream kinase of theor plasmids expressing indicated genes (2 mg each) and pCMV-lacZ
classical JNK kinase cascade, induced apoptosis upon(0.5 mg). HeLa cells were transfected with pEBB-Fas (1 mg) plus
plasmids expressing the indicated genes (3 mg each) and pCMV- ectopic expression (Johnson et al., 1996). Because the
lacZ (0.5 mg); Jo2 (12.5 ng/ml) addition and X-Gal staining were JNK pathway culminates in the activation of transcrip-
done as in Figure 6B. tion factors, the JNK pathway may directly or indirectly
(B) Inhibition of profile of Fas1Daxx, Daxx 501±625, and FADD in
counteract the expression of survival factors, such as293 cells. As in Figure 4B, 293 cells were transiently transfected
NF-kB and Bcl-2. It is well known that in many cellwith Fas, Daxx, Daxx 501±625, or FADD (1 mg each) plus empty
types, Fas-mediated apoptosis is greatly enhanced byvector or plasmids expressing the indicated apoptotic inhibitor
genes (3 mg each) and pCMV-lacZ (0.5 mg). transcriptional and translational inhibitors, suggesting
(C) Two pathways of Fas signaling that induce cell death. an important role for the modulation of gene expression
during apoptosis.
However, the involvement of the JNK pathway in
have shown that TRADD-mediated apoptosis is not apoptosis is commonly analyzed by dominant-negative
blocked by Bcl-2 (Hsu et al. 1995). Consistent with the proteins and may be complicated by several factors. For
two pathway model, the residual Fas-induced death re- example, Fas-mediated apoptosis has been reported to
maining after either DaxxC or FADD(80±205) treatment not involve JNK in Jurkat cells (Lenczowski et al., 1997)
are qualitatively different: the apoptosis remaining after but to require JNK in SHEP cells (Goillot et al., 1997).
FADD(80±205) treatment is Bcl-2 sensitive, but the These results may reflect a cell-type-dependent varia-
apoptosis remaining after DaxxC treatment is not (Figure tion of the relative contribution of Daxx and FADD path-
7A, lanes 8 and 9). Our results suggest that Fas activates ways. Alternatively, a negative result may reflect the
two distinct cell death pathwaysÐone via FADD that is functional redundancy of kinase isoforms in the MAP
Bcl-2 insensitive and a second one via Daxx that acti- kinase cascades that make up the JNK and p38/Mpk2
vates JNK and is Bcl-2 sensitive. pathways. Another possibility is that various tissue cul-
ture cell linesare originally derived from different tumors,
Discussion and oncogenes, such as Ha-Ras, are known to activate
the JNK pathway (Hibi et al., 1993; Derijard et al., 1994),
Daxx Is the Missing Link between Fas giving different basal JNK activity in different cell lines.
and the JNK Pathway As the most receptor-proximal protein leading to JNK
The Fas±FADD±FLICE connection is currently the best activation, Daxx may be an experimentally tractable tar-
understood model for apoptotic signal transduction get for dissecting the contribution of JNK signals to Fas-
(Fraser and Evan, 1996; Nagata, 1997), but its inability induced cell death. One prime example is in HeLa cells.
to explain Fas-induced JNK activation suggests that Although dominant-negative inhibitors of the JNK path-
the current model is at best incomplete. We and other way did not inhibit Fas-induced death in HeLa cells,
HeLa cells clearly employ Daxx and the JNK pathwayinvestigators have demonstrated that Fas can robustly
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C17 (Santa Cruz Biotech) were obtained from the indicated sources.as shown by the ability of DaxxC to block Fas-induced
HeLa, 293, and L929 were obtained originally from American TypeJNK activation and cell death (Figures 6 and 7).
Culture Collection (ATCC). To establish the L/Daxx cell line, HA-
Daxx vector was cotransfected with pBabe-puro into L929 cells.
Resistant cells were selected in media containing 2.5 mg/ml ofDaxx and FADD Define Two Distinct Fas-Induced
puromycin, and HA-Daxx-expressing clones were identified by im-Pathways to Apoptosis
munoblot analysis using anti-HA antibody 12CA9. The L929 cellsIn this study, we present several lines of evidence that
expressing mFas (L/Fas) were established by transfecting pRc/
Daxx and FADD bind to Fas independently and activate CMV-mFas into L929 cells and subsequently selecting for resistant
distinct cell death signals. Although both Daxx and cells in 600 mg/ml G418. Resistant clones were then screened for
FADD cannot bind to the lprcg point mutant of Fas, NMR Fas expression by FACScan using Jo2 antibody.
structural analysis of the Fas death domain suggest that
this mutant may be unfolded and is thus uninformative Plasmid Construction
for mapping the exact site of binding (Huang et al., 1996). DNA fragments for most plasmid constructs were obtained by PCR
amplification using Pfu polymerase (Stratagene) and primers incor-However, Daxx has no evident death domain and inter-
porated with appropriate restriction sites and epitope tags asacts with Fas death domain via a novel domain con-
needed. The fragments for LexA and transcription activator fusionstained in the 112 amino acids of DaxxC, while FADD
were cloned into plasmid pEG202 and pJG4±5 (Gyuris et al., 1993),interacts with Fas via homotypic death domain±death
respectively. The I225N mutation in LexA-lprcg was made by PCR
domain interactions. In addition, the Daxx±Fas interac- site-directed mutagenesis. GST constructs were made in pGEX vec-
tion is not affected by the C-terminal 15 amino acids of tor (Pharmacia). In vitro translation constructs were made in pET3a
(Novagen) or 6HisT-pRSET (A. Hoffmann, MIT) for DaxxC.Fas (Figure1), while theFADD±Fas interaction is partially
Daxx(2162) was obtained by digestion of a full-length Daxx con-inhibited by this C-terminal ªsalvation domainº of Fas
struct with HindIII. For expressing proteins in mammalian cells, full-(Chinnaiyan et al., 1995). These differences between
length Daxx and FADD and their mutants were cloned into pEBBFADD and Daxx are consistent with a model of FADD
with a hemagglutinin (HA) epitope tag at the 59 end. Full-length
and Daxx binding to distinct surfaces of the Fas death murine Fas was cloned into pEBB and pRc/CMV (Invitrogen). Fas
domain. We have produced mutations in the intracellular intracellular region (amino acids 165±306)was fused to GST in pEBG,
a derivative of pEBB expressing GST. Full-length murine TNFR1tail of Fas that selectively bind either Daxx or FADD
was cloned into pEBB. Each construct was confirmed by partial(X. Y., H. Y. C., and D. B., unpublished data). Moreover,
DNA sequence and by immunoblot analysis.dominant-negative forms of Daxx and FADD (each con-
The following plasmids were described in or obtained from thesisting of the minimal Fas-binding domains) did not in-
indicated sources: LexA-CD40IC (G. Cheng, UCLA), LexA-Bicoid
hibit the heterologous protein's biologic function even (Gyuris et al., 1993), pHD1.2 (crmA) and pBabe-Bcl-2 (J. Yuan, Har-
at saturating levels (Figure 7). This last result in particular vard), Bcl-XL (R. J. Lutz, Apoptosis Inc.), TAM67 and Flag-JNK (M.
Karin, UCSD), pEBG-SEK(AL) (C. J. Der, UNC), SRE-L-Luc (R. Treis-suggests that Daxx and FADD bind toFas independently
man, ICRF, UK).in vivo.
Daxx and FADD not only appear to bind differently to
Fas but transduce physiologically distinct death signals. Two-Hybrid Screen and b-Galactosidase Assay
The two-hybrid screen was performed essentially as described (Gy-As summarized by the model in Figure 8C, FADD directly
uris et al., 1993). Among 1 3 106 library plasmids screened, 33binds FLICE and is thought to induce apoptosis by re-
interacting clones were obtained. The cDNA inserts of the librarycruiting FLICE and activating a caspase cascade. How-
plasmids within those colonies were isolated and grouped. Repre-
ever, this pathway cannot activate JNK. By contrast, sentative plasmids from each group were retransformed back into
Daxx transduces an apoptotic signal via JNK (Figure yeast to test their interaction with different baits.
8C). Because inhibition of caspases did not block JNK For assaying b-Galactosidase expression, each pair of DNA-bind-
ing (LexA) and activation hybrids were cotransfected together theactivation but blocked Daxx-induced cell death, thecas-
lacZ reporter plasmid pSH18±34 (Gyuris et al., 1993) into EGY48pases are placed downstream of Daxx and JNK (Figure
yeast cells. Filter lift assay for colony color and quantitative liquid8C). The Daxx pathway is also sensitive to Bcl-2 (Figures
assay were done as described (Yang et al., 1994) for 3±6 indepen-
7A and 8B). Although either the Daxx- or the FADD- dent transformants.
induced pathway alone is sufficient to activate cell
death, these two pathways probably work together in
cDNA Cloning and Northern Blot Analysisvivo. For example, in HeLa cells, both Daxx and FADD
The cDNA insert in clone A21 was used to screen a murine thymus
act downstream of Fas, and it is necessary to block cDNA library (Y. W. Choi, Rockefeller Univ.). Sequences of the lon-
both death signals to effectively protect the cell from gest cDNA clone (2.4kb) as well as the cDNA inserts of clone A21
were determined on both strands with an automated sequencerFas (Figure 7A). Why expand the number of potentially
(Applied Biosystem). Sequence comparison was done by usingdangerous cell suicide signals if one signal is sufficient?
GeneWorks program of IntelliGenetics, Inc. The Daxx amino acidsAs in the case of growth regulation, the collaboration of
501±739 exhibit 57% sequence identity to clone A21.multiple signaling pathways allows fine-tuned regulation
For Northern analysis, the C-terminal 0.7 kb fragment of murine
and creates multiple checkpoints for control. In this in- Daxx and a human b-actin cDNA (Clontech) were used to probe a
stance, incorporation of the Daxx pathway may allow mouse multiple tissue Northern blot (Clontech), according to the
manufacturer's protocol.the Fas death signal to be regulated by Bcl-2.
Experimental Procedures In Vitro Binding and Coprecipitation Assays
GST fusions were purified as described (Smith and Johnson, 1988).
35S-proteins were made with TNT Reticulocyte Lysate System (Pro-Reagents and Cell Lines
Anti-murine Fas Jo2 antibody was the generous gift of S. Nagata mega). 35S-proteins were incubated with 10 mg of each GST fusion
protein in 0.1 ml of modified E1A buffer (Hsu et al., 1996) with 50(Ogasawara et al., 1993). Murine TNF-a (Genzyme), monoclonal anti-
body M2 against Flag epitope (Kodak/IBI), and anti-JNK-1 antibody mM NaCl and 10% glycerol for 1±2 hr, washed three times, and
Daxx: A Novel Fas Effector
1075
analyzed by SDS±PAGE and autoradiography. A fraction of the reac- their generous gifts of reagents, and S. W. Fesik for examining the
Daxx sequence. We thank P. Svec and Y. Li for excellent technicaltion mixture was analyzed by Coomassie staining to visualize GST
fusion proteins. assistance, and Drs. A. J. Koleske, B. Chen, Z. Songyang, Y. Yama-
nashi, I. Stancovsky andother members of Baltimore lab for valuableFor testing association in mammalian cells, HA-Daxx and HA-
DaxxDC were cotransfected with GST-FasIC or GST into 293 cells advice. X. Y. and R. K.-F. are fellows of the Leukemia Society of
America and Irvington Research Institute, respectively. H. Y. C. isby calcium phosphate method. Thirty-six hours after cotransfection,
cells were solubilized in E1A buffer, precipitated with glutathione supported by the Medical Scientist Training Program at Harvard
Medical School. D. B. is an American Cancer Society Researchbeads (Molecular Probes), washed three times, and immunoblotted
for HA using ECL (Amersham). Comparable levels of GST fusions Professor. This work was supported by the NIH grant CA51462.
were verified by immunoblotting for GST.
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